FDG-PET/CT versus contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients

被引：0
|
作者：
Riedl, Christopher
Pinker, Katja
Ong, Leonard
Jochelson, Maxine S.
Ulaner, Gary
McArthur, Heather L.
Dickler, Maura N.
Weber, Wolfgang
机构：
[1] Mem Sloan Kettering Canc Ctr, Mol Imaging & Therapy Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.1051
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1051
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Does FDG-PET/CT obviate the need for standard diagnostic contrast-enhanced CT in patients with lymphoma?
    Elstrom, Rebecca L.
    Brown, Richard K. J.
    BLOOD, 2007, 110 (11) : 689A - 689A
  • [42] Assessment of PERCIST criteria of FDG-PET/CT to predict progression-free survival after carbon-ion radiotherapy in patients with locally advanced pancreas cancer.
    Nishii, Ryuichi
    Higashi, Tatsuya
    Yamada, Shigeru
    Isozaki, Yuka
    Kawashiro, Shohei
    Yoshinaga, Keiichiro
    Kamada, Tadashi
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [43] Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients
    Jung, Na Young
    Yoo, Ie Ryung
    Kang, Bong Joo
    Kim, Sung Hun
    Chae, Byung Joo
    Seo, Ye Young
    BREAST CANCER, 2016, 23 (01) : 141 - 148
  • [44] FDG-PET/CT for systemic staging of patients with newly diagnosed breast cancer
    Groheux, David
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1417 - 1419
  • [45] Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients
    Na Young Jung
    Ie Ryung Yoo
    Bong Joo Kang
    Sung Hun Kim
    Byung Joo Chae
    Ye Young Seo
    Breast Cancer, 2016, 23 : 141 - 148
  • [46] FDG-PET/CT for systemic staging of patients with newly diagnosed breast cancer
    David Groheux
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1417 - 1419
  • [47] Progression-free survival after surgical extirpation of the intact primary in patients with stage IV breast cancer
    Rao, R
    Kuerer, H
    Hunt, KK
    Hortobagyi, G
    Singletary, SE
    Ames, FC
    Meric-Bernstam, F
    Ross, MI
    Feig, BW
    Babiera, GV
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S16 - S16
  • [48] FDG-PET/CT versus bone scintigraphy for detection of bone metastases in breast cancer
    Grigolato, D.
    Cucca, M.
    Zuffante, M.
    Arini, A.
    Bonfante, L.
    Etta, L. E.
    Ferdeghini, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S134 - S134
  • [49] Analytics for Progression Free Survival and Distant Metastasis Prediction of Anal Cancer Patients After Chemoradiation Therapy Using Spatial Temporal FDG-PET/CT Features
    Chuong, M. D.
    Zhang, H. H.
    Wang, J.
    Latifi, K.
    Saeed, N.
    Tan, S.
    Choi, W.
    Hoffe, S. E.
    Shridhar, R.
    Lu, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E158 - E159
  • [50] Prone Versus Supine Breast FDG-PET/CT for Assessing Locoregional Disease Distribution in Locally Advanced Breast Cancer
    Abramson, Richard G.
    Lambert, Katrina F.
    Jones-Jackson, Laurie B.
    Arlinghaus, Lori R.
    Williams, Jason
    Abramson, Vandana G.
    Chakravarthy, A. Bapsi
    Yankeelov, Thomas E.
    ACADEMIC RADIOLOGY, 2015, 22 (07) : 853 - 859
12345